Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

por Balar, Arjun, Bajorin, Dean F., Milowsky, Matthew I.
Publicado 2011

Clinical states model for biomarkers in bladder cancer

por Apolo, Andrea B, Milowsky, Matthew, Bajorin, Dean F.
Publicado 2009

Novel strategies for treating relapsed/refractory urothelial carcinoma

por Iyer, Gopa, Milowsky, Matthew I, Bajorin, Dean F
Publicado 2010

Tracking the Workforce: The American Society of Clinical Oncology Workforce Information System

por Kirkwood, M. Kelsey, Kosty, Michael P., Bajorin, Dean F., Bruinooge, Suanna S., Goldstein, Michael A.
Publicado 2013

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

por Apolo, Andrea B., Riches, Jamie, Schöder, Heiko, Akin, Oguz, Trout, Alisa, Milowsky, Matthew I., Bajorin, Dean F.
Publicado 2010

Who Does Not Receive Treatment for Cancer?

por Ward, Marcia M., Ullrich, Fred, Matthews, Kevin, Rushton, Gerard, Goldstein, Michael A., Bajorin, Dean F., Hanley, Amy, Lynch, Charles F.
Publicado 2013

The High Incidence of Vascular Thromboembolic Events in Advanced Urothelial Cancer Treated with Platinum Chemotherapy Agents

por Tully, Christopher M., Apolo, Andrea B., Zabor, Emily C., Regazzi, Ashley M., Ostrovnaya, Irina, Rosenberg, Jonathan E., Bajorin, Dean F.
Publicado en Cancer (2015)

Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Non-Seminomatous Germ Cell Tumors

por Kundu, Shilajit D., Feldman, Darren R., Carver, Brett S., Gupta, Amit, Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Publicado en J Urol (2014)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

por Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Publicado en J Urol (2015)

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors

por Mano, Roy, Becerra, Maria F., Carver, Brett S., Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Feldman, Darren R., Sheinfeld, Joel
Publicado en J Urol (2016)

Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.

por Miller, Mariam Imnadze, Feifer, Andrew, Feldman, Darren R., Carver, Brett S., Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Publicado en Urology (2018)

Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Ca...

por Milowsky, Matthew I., Nanus, David M., Maluf, Fernando C., Mironov, Svetlana, Shi, Weiji, Iasonos, Alexia, Riches, Jamie, Regazzi, Ashley, Bajorin, Dean F.
Publicado en J Clin Oncol (2009)

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group

por Fabian, Carol J., Meyskens, Frank L., Bajorin, Dean F., George, Thomas J., Jeter, Joanne M., Khan, Shakila, Tyne, Courtney A., William, William N.
Publicado en J Clin Oncol (2016)

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

por Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
Publicado en Cell Rep (2018)

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

por Buckley, Michael T, Yoon, Joanne, Yee, Herman, Chiriboga, Luis, Liebes, Leonard, Ara, Gulshan, Qian, Xiaozhong, Bajorin, Dean F, Sun, Tung-Tien, Wu, Xue-Ru, Osman, Iman
Publicado 2007

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

por Funt, Samuel A., Patil, Sujata, Feldman, Darren R., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel, Tickoo, Satish K., Reuter, Victor E., Bosl, George J.
Publicado en J Clin Oncol (2019)

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

por Sharma, Padmanee, Shen, Yu, Wen, Sijin, Yamada, Sachiko, Jungbluth, Achim A., Gnjatic, Sacha, Bajorin, Dean F., Reuter, Victor E., Herr, Harry, Old, Lloyd J., Sato, Eiichi
Publicado 2007

A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder: A Retrospective Experience

por Dash, Atreya, Pettus, Joseph A., Herr, Harry W., Bochner, Bernard H., Dalbagni, Guido, Donat, S. Machele, Russo, Paul, Boyle, Mary G., Milowsky, Matthew I., Bajorin, Dean F.
Publicado 2008

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

por Apolo, Andrea B., Ostrovnaya, Irina, Halabi, Susan, Iasonos, Alexia, Philips, George K., Rosenberg, Jonathan E., Riches, Jamie, Small, Eric J., Milowsky, Matthew I., Bajorin, Dean F.
Publicado 2013

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

por Feldman, Darren R., Sheinfeld, Joel, Bajorin, Dean F., Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M., Bosl, George J., Motzer, Robert J.
Publicado 2010